Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients.

Canet, Luz MSánchez-Maldonado, Jose MCáliz, RafaelRodríguez-Ramos, AnaLupiañez, Carmen BCanhão, HelenaMartínez-Bueno, ManuelEscudero, AlejandroSegura-Catena, JuanaSorensen, Signe BHetland, Merete LSoto-Pino, María JoséFerrer, Miguel AGarcía, AntonioGlintborg, BenteFilipescu, IleanaPérez-Pampin, EvaGonzález-Utrilla, AlfonsoNevot, Miguel Ángel LópezConesa-Zamora, Pabloden Broeder, AlfonsDe Vita, SalvatoreJacobsen, Sven Erik HobeCollantes-Estevez, EduardoQuartuccio, LucaCanzian, FedericoFonseca, João ECoenen, Marieke J HAndersen, VibekeSainz, Juan2023-01-252023-01-252019http://hdl.handle.net/10668/13561The original version of this Article contained an error in the spelling of the author Ana Rodríguez-Ramos, which was incorrectly given as Ana Rodríguez Ramos. This has now been corrected in both the PDF and HTML versions of the Article.enCorrection: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients.research article30760878open access10.1038/s41397-019-0084-21473-1150https://www.nature.com/articles/s41397-019-0084-2.pdf